Effective immunotherapy against cancer Welcome to Immutep

We are a leading biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease. Find out about our technologies now!

OVERVIEW

This website immutep.com currently has an average traffic ranking of zero (the lower the higher page views). We have explored zero pages within the domain immutep.com and found four websites linking to immutep.com. There are three contacts and addresses for immutep.com to help you communicate with them. This website immutep.com has been on the internet for one thousand one hundred and forty-nine weeks, eight days, thirteen hours, and thirty-nine minutes.
Links to this site
4
Contacts
3
Locations
3
Online Since
Jun 2002

IMMUTEP.COM RANKINGS

This website immutep.com has seen varying quantities of traffic in the past the year.
Traffic for immutep.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for immutep.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for immutep.com

Date Range

All time
This Year
Last Year
Last Month

IMMUTEP.COM HISTORY

This website immutep.com was began on on June 30, 2002. It was updated on the date of April 18, 2014. This site will go back on the market on June 30, 2015. It is now one thousand one hundred and forty-nine weeks, eight days, thirteen hours, and thirty-nine minutes old.
REGISTERED
June
2002
UPDATED
April
2014
EXPIRED
June
2015

LENGTH OF LIFE

22
YEARS
0
MONTHS
8
DAYS

LINKS TO WEB SITE

Webdesign Homepage Erstellung - Contao Agentur Hamburg - Startseite

Homepage Erstellung und Responsive Webdesign mit dem CMS Contao aus Hamburg. Aus Hamburg entwickeln ich responsives Webdesign and erstelle Homepages mit dem CMS Contao.

PRIMA BIOMED

Committed to strong corporate governance. Pursuing opportunites in cancer immunotherapy. Committed to maintaining consistent and clear communications. Dedicated to leveraging its current technologies to develop innovative treatments.

WHAT DOES IMMUTEP.COM LOOK LIKE?

Desktop Screenshot of immutep.com Mobile Screenshot of immutep.com Tablet Screenshot of immutep.com

CONTACTS

IMMUTEP

None None

Parc Club Orsay 2 rue Jean Rostand

Orsay, 91893

FR

Immutep S.A.

Frederic Triebel

Parc Club Orsay, 2 rue Jean Rostand

Orsay, 91893

FR

Nexen Services

Hervé Leclerc

1 Rue Royale

Saint-Cloud, 92210

FR

IMMUTEP.COM HOST

I identified that a single page on immutep.com took nine hundred and ninety milliseconds to load. We could not observe a SSL certificate, so in conclusion we consider immutep.com not secure.
Load time
0.99 secs
SSL
NOT SECURE
Internet Protocol
85.13.133.184

NAME SERVERS

immutep.nexen.net
ns1.nexen.net

SERVER OS

I identified that this domain is using the Apache server.

PAGE TITLE

Effective immunotherapy against cancer Welcome to Immutep

DESCRIPTION

We are a leading biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease. Find out about our technologies now!

CONTENT

This website immutep.com has the following on the web site, "ANNOUNCING IMMUTEP FORMERLY PRIMA BIOMED." We analyzed that the webpage also said " Merck collaboration opens new opportunities." It also stated " IMP321 LAG-3Ig Keytruda in Melanoma - Expansion Cohort Initiates Dosing. Updated TACTI-mel Data presented at the Cambridge Healthtech Institutes Immuno-Oncology Summit. Immutep Commences Patient Dosing In Additional TACTI-mel Cohort. Maxim - Raises Capital 5. 4M, Extends Runway as IMP321 Expands to a New Combination Study with Keytruda. Share Purchase Plan Offer Document." The header had immunotherapeutics as the highest ranking search term. It was followed by LAG-3, vaccine, and MHC class II which isn't as ranked as highly as immunotherapeutics. The next words they used was adjuvant. CD223 was also included but might not be viewed by search crawlers.

SEEK OTHER DOMAINS

Home Immutines

Is een uitgebreid document voor u beschikbaar over het hoe, waarom en de noodzaak van Immutines . Met vriendelijke groet, De directie van Hak Agrofeed bv. Leemansstraat 2, 4251 LD Werkendam.

Immutopics Immunoassays for Calcium and Phosphate Regulation

Products will enhance our ability to serve the bone health research community. We Specialize in Innovative Assays for Accessing Calcium and Phosphate Regulation. For Quantitating Intact FGF-23 in Mouse and Rat.

ImmutriX Therapeutics, Inc.

Is a medical technology company located in Rapid City, South Dakota. Incorporated in the State of Delaware, it is privately funded and currently employs 26 people. An estimated seventy molecular targets can be removed by thi.

Immuunipuutospotilaiden yhdistys ry, Imppu ry, etusivu

Tervetuloa Immuunipuutospotilaiden yhdistyksen kotisivuille! Immuunipuutos on tila, jossa elimistön kyky puolustautua infektioita vastaan on häiriintynyt. Immuunipuutos voi olla primääri eli synnynnäinen tauti, tai sekundaarinen, eli esimerkiksi viruksen, leukemian tai lääkehoidon aiheuttama. Primäärit immuunipuutokset eivät ole tarttuvia.